Peptide Based Infection Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Aug-2017
  • Tables : 140
  • Figures : 42
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT188MR
  • Format : ppt

There is a need to develop novel therapeutic agents in order to fight infections. Peptide therapeutics are used to fight infectious diseases. The global peptide based infection therapeutics market is expected to grow in the future owing to factors such as cost effectiveness of peptides, higher efficacy of peptides in managing various disease indications and infections, and can be easily synthesized owing to smaller size. Moreover, few economic factors such as government policies for startup companies, increasing foreign direct investment, as well as higher investment in healthcare are also driving the global peptide based infection therapeutics market. The rising prevalence of infectious diseases has resulted in providing an impetus to the use of peptides therapeutics to treat infections. Along with this, emerging biotech and pharmaceutical companies, strong and advanced pipelines and patent expiries are few other aspects impacting the growth of the global peptide based infection therapeutics market positively. To support this, the advancements in technology and increased research and development and the rising investments in these fields have led to the growing importance of global peptide based infection therapeutics market. North America is expected to show higher attractiveness in this market.

Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. They are used in the treatment of infections owing to their broad spectrum of activities and mechanisms. They protect the host from pathogenic microbes and are also referred to as host defense peptides owing to their functionality in protecting the immunity system and fighting against infections.

According to Fact.MR’s research report on the global peptide based infection therapeutics market, the market is anticipated to show a robust growth rate during the forecasted period of 2017-2022 and expected to reflect a value a bit less than US$ 1.5 Bn.

Market Taxonomy

Drug

Distribution Channel

Telaprevir

Hospital Pharmacies

Boceprevir

Retail Pharmacies

 

Online Pharmacies

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Domination of North America in the Peptide Based Infection Therapeutics Market

With respect to the global peptide based infection therapeutics market, according to the market observation in 2016 and 2017, the region of North America is expected to dominate the global market in terms of higher market share by revenue and is poised to grow at a higher growth rate to register a CAGR during the period of forecast. North America shows higher market attractiveness; this growth mainly attributed to the higher investment in the healthcare industry along with rapid technological developments. Latin America and Middle East and Africa (MEA) regions show relatively slow growth rate as compared to North America region and a fairly less market share and this trend is anticipated to continue during the period of forecast, 2017 to 2022.

APEJ to Show Tremendous Activity as Compared to Europe

The Asia-Pacific excluding Japan (APEJ) region is expected to show a rapid growth rate and is expected to register a CAGR of 8.7% during the period of forecast. The main reasons for this kind of growth is the strict government regulations for the upcoming players, higher number of pharmaceutical companies, increased foreign direct investment and development of technologies. Moreover, the government encourages to increase the investment in the healthcare industry to discover and invent new methods and technologies to better the health of the patients and enhance patient outcome. Following Asia-Pacific excluding Japan (APEJ) region, Europe regions also shows good growth rate in the global peptide based infection therapeutics market.

Telaprivir Set to Dominate the Global Market

The telaprivir segment by drug type is expected to dominate the market in terms of market share by revenue, as of 2016 and expected to show a similar trend in 2017 as well. However, the boceprevir segment grows at a higher rate during the period of forecast as compared to telaprivir yet experiences less market share by revenue comparatively. However, with the higher rate of growth throughout the forecast period, it could be a case that the domination title might shift from telaprivir to boceprivir.

Online Pharmacies to Show Robust Growth Rate, Would Just be an Understatement

The online pharmacies segment by distribution channel is anticipated to show exponential growth rate to register a CAGR of 9.2% throughout the period of forecast, 2017 to 2022. This growth can be attributed towards the increasing awareness of the online concept, its effectiveness, reliability and convenience. However, this segment, still being in its nascent phase, has less market share as compared to other segments in the distribution channel category. The online segment is also expected to experience a higher gain in the BPS by the end of 2022. The online pharmacies segment reflects the highest growth in the North America region rate as compared to other regions during the period of forecast.

Hospital vs. Retail Pharmacies, a Touch Call to Make

Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market, as per market observations in 2016 and 2017. This trend could keep up with the growth rate that it reflects. However, the retail pharmacies segment shows a higher growth rate, yet less market share. It is anticipated to reflect a higher growth rate and poised to register a CAGR of 7.9% during the period of forecast of 2017 to 2022. The regions favoring the growth of the hospital pharmacy segment is APEJ followed by Europe. APEJ is also favorable for retail pharmacies segment, in fact the growth of retail pharmacies in this region is the highest as compared to other regions, as per anticipations. Asia-Pacific excluding Japan expected to stay strong with respect to all the segments by distribution channel, except for the online pharmacies segment which finds better shelter in North America region.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of the global peptide based infection therapeutics market through 2022, which include Vertex Pharmaceuticals Incorporated, Merck & Co., Inc. and Parchem Fine & Specialty Chemicals.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Peptide Based Infection Therapeutics Market - Executive Summary

2. Global Peptide Based Infection Therapeutics Market Overview
2.1. Introduction
       2.1.1. Global Peptide Based Infection Therapeutics Market Taxonomy
       2.1.2. Global Peptide Based Infection Therapeutics Market Definition
2.2. Global Peptide Based Infection Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Infection Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Infection Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Peptide Based Infection Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Infection Therapeutics Market Size and Forecast By Drug, 2012-2022
       3.1.1. Telaprevir Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Boceprevir Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region

4. Global Peptide Based Infection Therapeutics Market Analysis and Forecast By Distribution Channel 
4.1. Global Peptide Based Infection Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
       4.1.1. Hospital Pharmacies Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Retail Pharmacies Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Online Pharmacies Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Peptide Based Infection Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       5.1.1. North America Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.2. Latin America Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.3. Europe Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.4. Japan Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.5. APEJ Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.6. MEA Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. North America Peptide Based Infection Therapeutics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       6.1.1. Revenue (US$ Mn) Comparison, By Drug 
       6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
6.2. Canada Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       6.2.1. Revenue (US$ Mn) Comparison, By Drug 
       6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Latin America Peptide Based Infection Therapeutics Market Analysis and Forecast, By Country, 2012-2022
7.1. Brazil Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Drug 
       7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.2. Mexico Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Drug 
       7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.3. Argentina Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       7.3.1. Revenue (US$ Mn) Comparison, By Drug 
       7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Europe Peptide Based Infection Therapeutics Market Analysis and Forecast, By Country, 2012-2022
8.1. Germany Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Drug 
       8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.2. UK Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Drug 
       8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.3. France Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Drug 
       8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.4. Spain Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       8.4.1. Revenue (US$ Mn) Comparison, By Drug 
       8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.5. Italy Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       8.5.1. Revenue (US$ Mn) Comparison, By Drug 
       8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.6. Nordic Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       8.6.1. Revenue (US$ Mn) Comparison, By Drug 
       8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. Japan Peptide Based Infection Therapeutics Market Analysis and Forecast, By Country, 2012-2022
9.1. Japan  Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Drug 
       9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. APEJ Peptide Based Infection Therapeutics Market Analysis and Forecast, By Country, 2012-2022
10.1. China Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Drug 
       10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.2. India Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       10.2.1. Revenue (US$ Mn) Comparison, By Drug 
       10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.3. Malaysia Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       10.3.1. Revenue (US$ Mn) Comparison, By Drug 
       10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.4. Thailand Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       10.4.1. Revenue (US$ Mn) Comparison, By Drug 
       10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.5. Singapore Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       10.5.1. Revenue (US$ Mn) Comparison, By Drug 
       10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.6. Australia Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       10.6.1. Revenue (US$ Mn) Comparison, By Drug 
       10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. MEA Peptide Based Infection Therapeutics Market Analysis and Forecast, By Country, 2012-2022
11.1. GCC Countries Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Drug 
       11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.2. South Africa Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Drug 
       11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.3. Nigeria Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Drug 
       11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.4. Israel Peptide Based Infection Therapeutics Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Drug 
       11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

12. Global Peptide Based Infection Therapeutics Market Competition Landscape and Company Profile
12.1. Company Share Analysis By Region
12.2. Vertex Pharmaceuticals Incorporated
       12.2.1. Company Overview
       12.2.2. Peptide Based Infection Therapeutics Market Drug list
       12.2.3. Peptide Based Infection Therapeutics Market Drug Sales Data and Key Financials
       12.2.4. Key Developments
       12.2.5. SWOT Analysis
12.3.Merck & Co., Inc.
       12.3.1. Company Overview
       12.3.2. Peptide Based Infection Therapeutics Market Drug list
       12.3.3. Peptide Based Infection Therapeutics Market Drug Sales Data and Key Financials
       12.3.4. Key Developments
       12.3.5. SWOT Analysis
12.4. Parchem Fine & Speciality Chemicals
       12.4.1. Company Overview
       12.4.2. Peptide Based Infection Therapeutics Market Drug list
       12.4.3. Peptide Based Infection Therapeutics Market Drug Sales Data and Key Financials
       12.4.4. Key Developments
       12.4.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

TABLE 1 Global Peptide Based Infection Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Infection Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Infection Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Telaprevir Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Telaprevir Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Telaprevir Segment Market Share, By Region 2012-2016
TABLE 7 Global Telaprevir Segment Market Share, By Region 2017-2022
TABLE 8 Global Telaprevir Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Boceprevir Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Boceprevir Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Boceprevir Segment Market Share, By Region 2012-2016
TABLE 12 Global Boceprevir Segment Market Share, By Region 2017-2022
TABLE 13 Global Boceprevir Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global Hospital Pharmacies Segment Market Share, By Region 2012-2016
TABLE 17 Global Hospital Pharmacies Segment Market Share, By Region 2017-2022
TABLE 18 Global Hospital Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Retail Pharmacies Segment Market Share, By Region 2012-2016
TABLE 22 Global Retail Pharmacies Segment Market Share, By Region 2017-2022
TABLE 23 Global Retail Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Online Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Online Pharmacies Segment Market Share, By Region 2012-2016
TABLE 27 Global Online Pharmacies Segment Market Share, By Region 2017-2022
TABLE 28 Global Online Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 29 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 30 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 31 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 32 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 33 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 34 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 35 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 36 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 37 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 38 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 39 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 40 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 41 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 42 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 43 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 44 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 45 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 46 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 47 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 48 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 49 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 50 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 51 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 52 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 53 US Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 54 US Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 55 US Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 56 US Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 57 Canada Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 58 Canada Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 59 Canada Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 60 Canada Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 61 Brazil Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 62 Brazil Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 63 Brazil Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 64 Brazil Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 65 Mexico Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 66 Mexico Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 67 Mexico Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 68 Mexico Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 69 Argentina Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 70 Argentina Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 71 Argentina Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 72 Argentina Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 73 Germany Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 74 Germany Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 75 Germany Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 76 Germany Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 77 UK Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 78 UK Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 79 UK Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 80 UK Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 81 France Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 82 France Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 83 France Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 84 France Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 85 Spain Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 86 Spain Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 87 Spain Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 88 Spain Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 89 Italy Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 90 Italy Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 91 Italy Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 92 Italy Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 93 Nordic Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 94 Nordic Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 95 Nordic Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 96 Nordic Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 97 Japan  Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 98 Japan  Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 99 Japan  Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 100 Japan  Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 101 China Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 102 China Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 103 China Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 104 China Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 105 India Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 106 India Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 107 India Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 108 India Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 109 Malaysia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 110 Malaysia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 111 Malaysia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 112 Malaysia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 113 Thailand Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 114 Thailand Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 115 Thailand Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 116 Thailand Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 117 Singapore Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 118 Singapore Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 119 Singapore Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 120 Singapore Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 121 Australia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 122 Australia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 123 Australia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 124 Australia Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 125 GCC Countries Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 126 GCC Countries Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 127 GCC Countries Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 128 GCC Countries Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 129 South Africa Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 130 South Africa Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 131 South Africa Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 132 South Africa Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 133 Nigeria Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 134 Nigeria Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 135 Nigeria Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 136 Nigeria Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 137 Israel Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 138 Israel Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 139 Israel Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 140 Israel Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022

FIG. 1 Global Peptide Based Infection Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Infection Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Infection Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Telaprevir Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Telaprevir Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Telaprevir Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Boceprevir Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Boceprevir Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Boceprevir Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 20 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 21 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 22 North America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 23 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 24 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 25 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 26 Latin America Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 27 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 28 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 29 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 30 Europe Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 31 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 32 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 33 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 34 Japan Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 35 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 36 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 37 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 38 APEJ Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 39 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 40 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 41 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 42 MEA Peptide Based Infection Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development